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Hearing loss is one of the most common 
chronic disabling conditions among older 
adults (Bainbridge et al. 2008). More than 
35 million people ≥ 18 years of age suf-
fer from hearing loss in the United States 
in 2008, and the prevalence of hearing loss 
tends to increase dramatically with advanc-
ing age (Pleis and Lethbridge-Cejku 2006). 
Loud noise exposure at workplaces (Choi 
et al. 2012) and from firearms (Agrawal et al. 
2009) is a well-established risk factor. A grow-
ing body of evidence suggests that exposure to 
ototoxic environmental and industrial chemi-
cals also may impact the auditory system and 
lead to hearing loss (Agrawal et al. 2009; 
Bainbridge et al. 2008).
Experimental studies suggest that lead 
exposure induces degeneration in the inner 
ear receptor cells and latency in auditory 
nerve conduction velocity (Jones et al. 2008; 
Lasky et al. 1995; Yamamura et al. 1989) 
and that cadmium exposure causes apoptosis 
and alters the arrangement of inner ear recep-
tor cells leading to an elevation in auditory 
thresholds (Kim et al. 2008; Ozcaglar et al. 
2001). However, few epidemiologic studies of 
the association between low-level lead expo-
sure and hearing loss have been conducted 
in the general population (Park et al. 2010), 
and there is only one epidemiologic study on 
cadmium exposure and hearing loss in U.S. 
adolescents (Shargorodsky et al. 2011).
The aim of this study was to investigate 
the associations of environmental cadmium 
and lead exposure with hearing loss in a 
representative sample of U.S. adults who par-
ticipated in the National Health and Nutrition 
Examination Survey (NHANES) 1999–2004, 
while controlling for important potential con-
founding factors, including exposure to loud 
noises at work (occupational), from firearms, 
and during recreational activities. We also esti-
mated the joint effects of cadmium and lead, 
as well as effect modification by noise and 
other  potential risk factors.
Methods
Study population. NHANES, which is con-
ducted by the Centers for Disease Control 
and Prevention (CDC), National Center for 
Health Statistics (NCHS), is an ongoing series 
of cross-sectional surveys designed to obtain 
information from a representative sample of 
the civilian noninstitutionalized U.S. popu-
lation. Data are collected through extensive 
household interviews to obtain information 
on health risk factors, including health behav-
iors, personal environment, and lifestyle. In 
addition, physical examinations and medical 
history interviews were conducted at a specially 
equipped mobile examination center (MEC) 
(CDC 2007a).
In the 1999–2004 NHANES, half of the 
participants 20–69 years of age were randomly 
assigned to the Audiometry Examination 
Component at MEC. Participants who used 
hearing aids that could not be removed for test-
ing or who could not tolerate test headphones 
were excluded (CDC 2005). The initial sample 
size that was eligible for inclusion in the audio-
metric examination was 5,742 participants: 
1,807 in 1999–2000, 2,046 in 2001–2002, 
and 1,889 in 2003–2004. An additional 479 
participants were excluded because of non-
responses or unreliable responses during the 
audiometric examination.
For the present analysis, we excluded 
partici pants with unilateral hearing loss 
(n = 452) and those with missing informa-
tion on blood cadmium or lead measurements 
(n = 183), longest job-related Occupational 
Information Network (O*NET) score 
(n = 376), firearm or recreational noise expo-
sure (n = 6), or other demographic or hear-
ing-related variables (n = 548), leaving a total 
of 3,698 observations. Compared with the 
participants with audiometric data who were 
excluded from our analysis, participants with 
audiometric data who were included had lower 
hearing thresholds, were less likely to be clas-
sified as having hearing loss, and were more 
likely to have completed high school and to 
be non-Hispanic white [see Supplemental 
Material, Table S1 (http://dx.doi.org/10.1289/
ehp.1104863)]. We excluded an additional 76 
participants (2.1%) who had hearing thresh-
olds ≤ 0 dB (indicating better-than-normal 
hearing) from the linear regression models 
(n = 3,622) to better interpret regression results 
and to avoid adding a constant before log-
transformation of hearing thresholds.
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Background: Although cadmium and lead are known risk factors for hearing loss in animal 
 models, few epidemiologic studies have been conducted on their associations with hearing ability in 
the general population.
oBjectives: We investigated the associations between blood cadmium and lead exposure and hearing 
loss in the U.S. general population while controlling for noise and other major risk factors contributing 
to hearing loss.
Methods: We analyzed data from 3,698 U.S. adults 20–69 years of age who had been randomly 
assigned to the National Health and Nutrition Examination Survey (NHANES) 1999–2004 
Audiometry Examination Component. Pure-tone averages (PTA) of hearing thresholds at frequencies 
of 0.5, 1, 2, and 4 kHz were computed, and hearing loss was defined as a PTA > 25 dB in either ear.
results: The weighted geometric means of blood cadmium and lead were 0.40 [95% confidence 
interval (CI): 0.39. 0.42] µg/L and 1.54 (95% CI: 1.49, 1.60) µg/dL, respectively. After adjusting 
for sociodemographic and clinical risk factors and exposure to occupational and nonoccupational 
noise, the highest (vs. lowest) quintiles of cadmium and lead were associated with 13.8% (95% CI: 
4.6%, 23.8%) and 18.6% (95% CI: 7.4%, 31.1%) increases in PTA, respectively (p-trends < 0.05).
conclusions: Our results suggest that low-level exposure to cadmium and lead found in the general 
U.S. population may be important risk factors for hearing loss. The findings support efforts to reduce 
environmental cadmium and lead exposures.
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NHANES is a publicly available data set, 
and all participants in NHANES provide writ-
ten informed consent, consistent with approval 
by the NCHS Institutional Review Board.
Audiometric measurement. Audiometry 
examinations were conducted in a sound-
isolated room by health technicians trained 
by an audiologist certified by the National 
Institute for Occupational Safety and Health. 
Instrumentation for the audiometry compo-
nent included an audiometer (model AD226; 
Interacoustics, Assens, Denmark) with standard 
headphones (model TDH-39) and insert ear-
phones (Etymotic EarTone 3A) (CDC 2005). 
Pure-tone air conduction hearing thresholds 
were obtained for both ears at frequencies of 
0.5–8 kHz over an intensity range of –10 to 
120 dB. Results for examinees who did not 
respond to at least one frequency were classified 
as nonresponses (n = 476). As an additional 
measure of the quality of participants’ responses, 
the 1‑kHz frequency was tested twice in each 
ear, and audiograms with ≥ 10 dB difference 
between the tests were classified as  unreliable 
responses (n = 3) (CDC 2005).
We computed the hearing thresholds 
(decibel) at speech frequencies as a pure-
tone average (PTA) of 0.5, 1, 2, and 4 kHz 
(Agrawal et al. 2009). Hearing loss was defined 
as a PTA ≥ 25 dB in either ear, consistent 
with the definition used by the World Health 
Organization (Ikeda et al. 2009).
Blood cadmium and lead measurements. 
Blood cadmium and lead were measured at the 
Environmental Health Sciences Laboratory of 
the CDC, National Center for Environmental 
Health (NCEH; Atlanta, GA) after confirm-
ing the absence of background contamination 
in all collection and storage materials (CDC 
2001a). Cadmium and lead concentrations 
were measured by a simultaneous multi element 
atomic absorption spectrometer (SIMAA 
6000; PerkinElmer, Norwalk, CT) with 
Zeeman background correction in NHANES 
1999–2002 (CDC 2001a, 2001b) and by an 
inductively coupled plasma-mass spectrometer 
(ELAN 6100; PerkinElmer, Shelton, CT) in 
NHANES 2003–2004 (CDC 2004a).
The detection limit for cadmium was 
0.3 µg/L in NHANES 1999–2002 and 
0.2 µg/L in NHANES 2003–2004; the detec-
tion limit for lead was 0.3 µg/dL in all three 
NHANES cycles. Of the study participants, 
26% and 17% had cadmium concentrations 
below the detection limit in NHANES 1999–
2002 and NHANES 2003–2004, respectively; 
0.8% of all participants had blood lead con-
centrations below the detection limit (CDC 
2004a, 2004b, 2007c). For these partici-
pants, we imputed a value equal to the detec-
tion limit divided by the square root of two 
(CDC 2007b). Interassay coefficients of varia-
tion (CV) ranged from 6.1% to 7.3% and 
from 4.1% to 4.4% for low and high blood 
cadmium quality control (QC) pools, and 
from 4.0% to 7.0% and 3.1% to 3.2% for 
the low and high blood lead QC pools (CDC 
2001a, 2001b, 2004b). 
Noise exposure assessments. Noise exposures 
(e.g., occupational, firearm, recreational noise) 
may be important confounding factors in the 
associations of blood cadmium and lead with 
hearing loss. Direct measures of personal noise 
exposure are not available in the NHANES. 
Participants were classified as exposed (vs. 
unexposed) to nonoccupational firearm noise if 
they indicated that they had ever been exposed 
to the noise of a firearm at least once a month 
for 1 year, and were classi fied as exposed to 
recreational noise if they indicated exposure to 
loud noise outside of work (e.g., power tools or 
loud music) at least once a month for 1 year.
Occupational noise exposures were classi-
fied based on occupational noise estimates 
according to the job title for the longest job 
held by each participant. These estimates were 
based on a new occupational noise exposure 
assessment tool that uses the O*NET survey 
database (Choi et al. 2012). In brief, the lon-
gest job-related O*NET score (range, 1–5) was 
assigned to each participant as a proxy measure 
of personal exposure to occupational noise. The 
median value of the occupational noise score 
was used to divide participants into low and 
high occupational noise exposure groups.
Demographic and hearing-related vari-
ables. Information on other demographic and 
hearing-related variables was obtained during 
household interviews or at the MEC. Body 
mass index (BMI) was calculated as dividing 
measured weight in kilograms by measured 
height in meters squared. Use of ototoxic 
medi cation was defined based on self-reported 
use of any aminoglycosides, loop diuretics, 
anti neoplastic drugs, or nonsteroidal anti-
inflammatory drugs during the past month. 
Smoking pack-years were computed, and 
partici pants were classified as nonsmokers, 
smokers with < 20 pack-years, or smokers with 
≥ 20 pack-years. Hypertension was classified 
based on a self-reported physician diagnosis, 
current use of antihypertensive medication, or 
systolic blood pressure ≥ 140 mmHg or dia-
stolic blood pressure ≥ 90 mmHg at the time 
of examination. Diabetes mellitus was classified 
based on a self-reported physician diagnosis or 
current use of antihyperglycemic medication, 
consistent with a previous study of diabetes 
and hearing loss (Bainbridge et al. 2008).
Statistical analysis. All statistical analy-
ses were performed using SAS survey proce-
dures (version 9.2; SAS Institute Inc., Cary, 
NC) and the R survey package (version 2.9.1; 
R Foundation for Statistical Computing, 
Vienna, Austria) to account for the complex 
survey design and NHANES sample weights 
(CDC 2007a). We computed 6-year sample 
weights per NCHS recommendations, which 
were adjusted for oversampling and non-
participation of ethnic minorities, the elderly, 
and low-income persons (CDC 2007a). Two-
sided p-value < 0.05 was considered statistical 
significance.
Hearing thresholds for PTA and individ-
ual frequencies were log-transformed to nor-
malize distributions, and linear regression was 
used to model these outcomes. Blood lead 
and cadmium were log-transformed based 
on graphical evaluations suggesting improved 
fit compared with model estimates for non-
transformed exposures, although estimates 
based on fully adjusted natural spline models 
indicated nonlinear associations with both 
log-transformed and nontransformed expo-
sure variables [see Supplemental Material, 
Figure S1 (http://dx.doi.org/10.1289/
ehp.1104863)]. Therefore, we also modeled 
quintiles of blood cadmium and lead to better 
capture nonlinear relationships. We estimated 
the percent change in hearing threshold 
for a doubling of the blood cadmium and 
blood lead as (e(ln2 × β) –1) × 100%, with 
95% confidence intervals (CI) estimated as 
(e[ln2 × (β ± 1.96 × SE)] –1) × 100%, where β and 
SE are the estimated regression coefficient 
and standard error. For quintiles, percent 
changes were estimated by comparing each of 
the upper four quintiles to the lowest quintile. 
p-Values for a linear trend were computed 
by fitting the exposure quintile as an ordinal 
cate gori cal variable coded using integer values 
(0–4). Logistic regression was used to estimate 
odds ratios (ORs) for the hearing loss defined 
as PTA ≥ 25 dB in one or both ears.
We used sequential models to assess the 
influence of potential confounders: a) model A 
was adjusted for age and age2, sex, race/
ethnicity [non-Hispanic white (reference), 
Mexican American, non-Hispanic black, 
other], education [< high school (reference), 
high school, > high school], BMI (continuous), 
ototoxic medication use (yes/no), cigarette 
smoking [never smoker (reference), < 20 pack-
years, ≥ 20 pack-years], hypertension (yes/
no), type 2 diabetes (yes/no), and either blood 
lead or blood cadmium (for the corresponding 
cadmium or lead model); b) model B further 
adjusted for occupational noise exposure 
(O*NET score, continuous); and c) model 
C further adjusted for any nonoccupational 
firearm noise (yes/no) and any recreational 
noise (yes/no). We kept hypertension and 
type 2 diabetes in model A, although these 
variables could be potential intermediates 
between lead or cadmium exposure and 
hearing loss (Bainbridge et al. 2008; Chang 
et al. 2011), because the effect estimates 
between the models with and without 
adjustment for hypertension and diabetes were 
not much different (data not shown).
We also evaluated fully adjusted associa-
tions with log-transformed PTA for subgroups 
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defined by age (20–39, 40–59, ≥ 60 years of 
age), sex, BMI (< 30, ≥ 30 kg/m2), education, 
ototoxic medication use, cigarette smoking/
pack-years, hypertension, diabetes, and occupa-
tional (< 2.84, ≥ 2.84 O*NET score), firearm, 
and recreational noise exposure.
Joint effects of blood cadmium and lead 
with log-transformed PTA were examined in 
fully adjusted models using a combined cate-
gori cal variable classified as low cadmium and 
low lead (reference), high cadmium and low 
lead, low cadmium and high lead, or high 
cadmium and high lead, with high and low 
categories defined based on median values 
for all study participants. Departures from 
additive joint effects [relative excess risk due 
to inter action (RERI)] and multiplicative 
joint effects were computed as recommended 
by Knol and VanderWeele (2012) with the 
95% CI for the RERI computed by the delta 
method (Hosmer and Lemeshow 1992).
Results
Weighted means ± SE of age and PTA were 
42.06 ± 0.28 years and 12.78 ± 0.24 dB, 
respectively [see Supplemental Material, 
Table S2 (http://dx.doi.org/10.1289/
ehp.1104863)]. Overall, 441 participants 
(11.9%) had hearing loss (PTA ≥ 25 dB 
in one or both ears). The age-adjusted geo-
metric means (95% CIs) of blood cadmium 
and lead in the entire population were 0.40 
(95% CI: 0.39, 0.42) µg/L and 1.54 (95% 
CI: 1.49, 1.60) µg/dL, respectively (Table 1). 
Compared with participants without hearing 
loss, those with hearing loss had significantly 
higher age-adjusted geometric mean blood 
cadmium (0.46; 95% CI: 0.42, 0.50 µg/L 
vs. 0.40; 95% CI: 0.38, 0.42 µg/L) and lead 
(1.72; 95% CI: 1.62, 1.82 µg/dL vs. 1.52; 
95% CI: 1.47, 1.58 µg/dL) levels, respectively. 
Age-adjusted blood cadmium and lead levels 
differed by race/ethnicity and were higher in 
participants who were older, less educated, 
and ever smokers, and in those with high 
occupational noise exposure, BMI < 30, 
and no diabetes. Blood lead levels also were 
higher in men, in participants who did not use 
ototoxic medications, and among participants 
who were exposed to firearm noise and among 
those who were exposed to recreational 
noise. Blood cadmium levels were higher 
in women. Blood cadmium and lead levels 
were highly  correlated (Spearman  correlation 
 coefficient = 0.12, p < 0.001).
Table 2 presents the estimated percent 
changes in PTA in association with blood 
cadmium and lead levels. Blood cadmium 
and lead levels, both as continuous variables 
and when modeled as quintiles, were posi-
tively associated with higher (poorer) hearing 
thresholds in all models. In the fully adjusted 
model (model C), subjects in the highest 
blood cadmium quintile had 13.8% (95% 
CI: 4.6%, 23.8%) higher hearing thresholds 
than did those in the lowest quintile. A dou-
bling of blood cadmium was associated with 
a 4.1% (95% CI: 1.2%, 7.1%) increase in 
hearing thresholds. Similarly, subjects in the 
highest blood lead quintile had 18.6% (95% 
CI: 7.4%, 31.1%) higher hearing thresholds 
than did those in the lowest quintile, and a 
doubling of blood lead was associated with a 
5.4% (95% CI: 2.1%, 8.8%) increase in hear-
ing thresholds. Similar patterns of associations 
were observed between blood lead and indi-
vidual frequencies of 0.5, 1, and 4 kHz [see 
Supplemental Material, Figure S2 (http://
dx.doi.org/10.1289/ehp.1104863)].
Table 3 shows the logistic regression results 
for hearing loss in different covariate-adjusted 
models. Trend tests for blood cadmium levels 
were significant in all models. Associations 
with blood lead levels were significant before, 
but not after, adjusting for noise exposures. 
Fully adjusted ORs for hearing loss comparing 
the highest versus the lowest blood cadmium 
and lead quintiles were 1.7 (95% CI: 1.1, 2.7) 
and 1.4 (95% CI: 0.8, 2.5), respectively.
We estimated the individual and joint 
effects of exposures to cadmium and lead on 
the hearing thresholds (Table 4). Participants 
with both high cadmium and lead exposures 
(vs. both low) had a 19.0% (95% CI: 9.7%, 
29.1%) increase in PTA that was consistent 
with additive effects of high cadmium only 
(7.3%; 95% CI: 0.4%, 14.8%) and of high 
lead only (10.1%; 95% CI: 0.4%, 20.8%). 
Table 1. Age-adjusted geometric means (GMs) and 95% CIs of blood cadmium (µg/L) and lead (µg/dL) by 
participant characteristic (n = 3,698).
Characteristic 
Participants 
[n (%)]a Blood cadmiumb p-Valuec Blood leadb p-Valuec
Total 3,698 0.40 (0.39, 0.42) 1.54 (1.49, 1.60)
Hearing loss
No 3,257 (88.8) 0.40 (0.38, 0.42) 1.52 (1.47, 1.58)
Yes 441 (11.2) 0.46 (0.42, 0.50) 0.001 1.72 (1.62, 1.82) < 0.001
Age (years) 
20–39 1,650 (44.8) 0.36 (0.34, 0.38) 1.23 (1.18, 1.29)
40–59 1,385 (43.8) 0.44 (0.41, 0.46) 1.75 (1.67, 1.81)
60–69 663 (11.3) 0.45 (0.42, 0.48) 0.007 2.09 (1.98, 2.21) 0.004
Sex
Male 1,729 (48.6) 0.38 (0.36, 0.40) 1.94 (1.87, 2.02)
Female 1,969 (51.4) 0.43 (0.41, 0.45) < 0.001 1.24 (1.19, 1.31) < 0.001
BMI (kg/m2)
< 30 2,484 (69.0) 0.42 (0.39, 0.44) 1.61 (1.54, 1.69)
≥ 30 1,214 (31.0) 0.38 (0.36, 0.40) 0.003 1.40 (1.34, 1.47) < 0.001
Race/ethnicity
Non-Hispanic white 1,827 (72.5) 0.40 (0.38, 0.42) 1.48 (1.42, 1.55)
Non-Hispanic black 750 (10.5) 0.42 (0.39, 0.45) 1.77 (1.68, 1.87)
Mexican American 805 (6.6) 0.39 (0.36, 0.42) 1.81 (1.69, 1.95)
Other 316 (10.4) 0.46 (0.43, 0.49) 0.014 1.60 (1.47, 1.74) < 0.001
Education
< High school 974 (16.6) 0.55 (0.51, 0.58) 1.99 (1.89, 2.11)
High school 849 (25.1) 0.45 (0.42, 0.48) 1.62 (1.53, 1.71)
> High school 1,875 (58.3) 0.36 (0.34, 0.37) < 0.001 1.41 (1.35, 1.47) < 0.001
Ototoxic medication
No 3,132 (84.1) 0.40 (0.39, 0.42) 1.59 (1.53, 1.66)
Yes 566 (15.9) 0.41 (0.37, 0.45) 0.981 1.31 (1.23, 1.39) < 0.001
Cumulative cigarette pack-years
Never 2,105 (53.7) 0.29 (0.27, 0.30) 1.33 (1.27, 1.40)
< 20 1,183 (33.7) 0.58 (0.54, 0.61) 1.81 (1.73, 1.89)
≥ 20 410 (12.5) 0.68 (0.61, 0.76) < 0.001 1.89 (1.78, 2.01) < 0.001
Current diagnosis of hypertension
No 2,713 (76.8) 0.41 (0.39, 0.43) 1.56 (1.50, 1.62)
Yes 985 (23.2) 0.38 (0.36, 0.41) 0.071 1.49 (1.40, 1.59) 0.164
Current diagnosis of diabetes mellitus  
No 3,485 (95.9) 0.41 (0.39, 0.43) 1.56 (1.51, 1.62)
Yes 213 (4.1) 0.32 (0.28, 0.37) < 0.001 1.20 (1.07, 1.35) < 0.001
Occupational noise exposure (O*NET score)
Low (< 2.84) 1,815 (52.7) 0.37 (0.35, 0.38) 1.31 (1.25, 1.38)
High (≥ 2.84) 1,883 (27.3) 0.45 (0.43, 0.48) < 0.001 1.85 (1.77, 1.92) < 0.001
Firearm noise exposure
No 3,468 (92.5) 0.40 (0.39, 0.42) 1.52 (1.46, 1.57)
Yes 230 (7.5) 0.41 (0.36, 0.47) 0.872 1.94 (1.72, 2.18) < 0.001
Reacreational noise exposure
No 2,844 (74.0) 0.40 (0.38, 0.42) 1.47 (1.41, 1.54)
Yes 854 (26.0) 0.42 (0.39, 0.45) 0.184 1.77 (1.67, 1.88)  < 0.001
aWeighted percentages from survey frequency. bAge adjusted except for age groups, which are presented as the unad-
justed lead and cadmium levels. cWe used survey t-test for binominal groups and the Wald F-test for categorical groups.
Cadmium, lead, and hearing loss
Environmental Health Perspectives • volume 120 | number 11 | November 2012 1547
Estimates did not indicate departures from 
expectations for additive (RERI = 1.6%; 95% 
CI: –9.4%, 12.6%; p = 0.78) or multiplicative 
joint effects (percent change of inter action 
term = 0.7%; 95% CI: –8.9%, 11.39%; 
p = 0.89).
Figure 1 presents percent changes in 
PTA associated with a doubling of lead or 
cadmium by participant characteristics based 
on fully adjusted models. For blood cadmium, 
the association was stronger in non-Hispanic 
white compared with non-Hispanic black 
participants (p = 0.02). For blood lead, 
the association was stronger in other race/
ethnicity participants than in non-Hispanic 
whites (p = 0.01). There were borderline 
significant differences in associations between 
blood lead and PTA when we compared 
Mexican-Americans with non-Hispanic whites 
(p = 0.05), and participants who were not 
exposed to firearm noise with those who were 
exposed (p = 0.06).
Discussion
In a representative sample of U.S. adults 
who participated in NHANES 1999–2004, 
environmental cadmium and lead exposures 
were associated with hearing loss, even after 
adjusting for socioeconomic factors, noise 
exposures, and other potential risk factors. In 
addition, we observed positive dose–response 
relationships of hearing thresholds with blood 
cadmium and lead at levels currently observed 
in the general U.S. population. Compared 
with the lowest quintiles of cadmium and 
lead exposure, PTAs for participants in the 
highest quintiles were increased by 13.8% 
and 18.6%, respectively. These differences 
were consistent with estimated differences in 
PTAs associated with sex (18.4% higher in 
females vs. males), having diabetes (19.9%), 
and with a two-unit increase of O*NET occu-
pational noise scores (14.8%, correspond-
ing to the noise exposure difference between 
“Textile, apparel, and furnishings machine 
operators” versus “Executive, administra-
tors, and managers” occupation groups) [see 
Supplemental Material, Table S3 (http://
dx.doi.org/10.1289/ehp.1104863)].
Few epidemiologic studies have evaluated 
associations between low-level lead exposure 
and hearing outcomes. Our results extend lim-
ited evidence from occupational settings or 
studies of children (Discalzi et al. 1993; Forst 
et al. 1997; Schwartz and Otto 1991) to the 
general population. A previous study of 448 
elderly community-dwelling men in eastern 
Massachusetts reported a significant association 
between hearing loss and an interqurtile range 
increase in tibia and patella bone lead levels 
(OR = 1.2; 95% CI: 0.9, 1.5 and OR = 1.5; 
95% CI: 1.1, 1.9, respectively) (Park et al. 
2010). We estimated an increase in hearing 
thresholds of 4.1% (95% CI: 1.2%, 7.1%) and 
Table 2. Percent change (95% CI) in hearing thresholds (dB) by blood cadmium and lead levels (n = 3,622).
Variables
Participants 
(n) Model Aa Model Bb Model Cc
Cadmium 
Per doubling of cadmium 4.38 (1.43, 7.41) 4.07 (1.09, 7.15) 4.13 (1.19, 7.15)
Cadmium quintile (µg/L)
Quintile 1 (0.10–0.20) 1,013 Reference Reference Reference
Quintile 2 (0.30–0.30) 553 –1.02 (–8.75, 7.35) –1.53 (–9.22, 6.81) –1.22 (–8.86, 7.07)
Quintile 3 (0.40–0.40) 581 2.21 (–5.10, 10.08) 1.26 (–5.95, 9.02) 1.68 (–5.60, 9.53)
Quintile 4 (0.50–0.70) 785 7.07 (–1.07, 15.87) 6.53 (–1.58, 15.32) 6.69 (–1.48, 15.53)
Quintile 5 (0.80–8.50) 690 14.49 (5.17, 24.64) 13.42 (4.18, 23.48) 13.78 (4.55, 23.82)
p-Trend 0.003 0.006 0.005
Lead 
Per doubling of lead 6.24 (2.88, 9.71) 5.68 (2.35, 9.13) 5.41 (2.12, 8.81)
Lead quintile (µg/dL)
Quintile 1 (0.20–0.80) 629 Reference Reference Reference
Quintile 2 (0.90–1.30) 842 –0.04 (–9.50, 10.41) –0.06 (–9.51, 10.38) –0.50 (–9.94, 9.93)
Quintile 3 (1.40–1.80) 679 7.30 (–3.05, 18.76) 7.11 (–3.23, 18.54) 6.51 (–3.76, 17.89)
Quintile 4 (1.90–2.70) 734 11.86 (0.97, 23.92) 11.01 (0.26, 22.91) 10.22 (–0.40, 21.97)
Quintile 5 (2.80–54.00) 738 21.13 (9.43, 34.09) 19.44 (7.96, 32.14) 18.63 (7.35, 31.09)
p-Trend   < 0.001 < 0.001 < 0.001
aModel A was adjusted for age, age2, sex, race/ethnicity, education, BMI, ototoxic medication, pack-years of cigarette 
smoke, hypertension, and diabetes. Cadmium models were further adjusted for lead; lead models were further adjusted 
for cadmium. bModel B adjusted for all variables included in Model A and further adjusted for occupational noise. 
cModel C adjusted for all variables in Model B and further adjusted for recreational noise and firearm noise.
Table 3. ORs (95% CIs) for hearing lossa by blood cadmium and lead levels (n = 3,698).
Variables
No. with hearing loss/ 
no. of participants Model Ab Model Bc Model Cd 
Cadmium
Per doubling of cadmium 1.28 (1.09, 1.50) 1.26 (1.07, 1.49) 1.26 (1.07, 1.47)
Cadmium quintile (µg/L)
Quintile 1 (0.10–0.20) 71/1,047 Reference Reference Reference
Quintile 2 (0.30–0.30) 53/566 1.20 (0.71, 2.05) 1.17 (0.69, 1.99) 1.21 (0.71, 2.05)
Quintile 3 (0.40–0.40) 72/593 1.07 (0.72, 1.58) 1.01 (0.68, 1.50) 1.05 (0.71, 1.55)
Quintile 4 (0.50–0.70) 128/796 1.44 (0.96, 2.16) 1.39 (0.92, 2.11) 1.39 (0.91, 2.11)
Quintile 5 (0.80–8.50) 117/696 1.80 (1.14, 2.85) 1.72 (1.08, 2.76) 1.74 (1.12, 2.70)
p-Trend 0.009 0.017 0.013
Lead
Per doubling of lead 1.13 (0.98, 1.30) 1.11 (0.96, 1.28) 1.09 (0.95, 1.26)
Lead quintile (µg/dL)
Quintile 1 (0.20–0.80) 21/659 Reference Reference Reference
Quintile 2 (0.90–1.30) 61/872 1.10 (0.57, 2.10) 1.12 (0.58, 2.15) 1.08 (0.55, 2.12)
Quintile 3 (1.40–1.80) 80/689 1.14 (0.62, 2.09) 1.14 (0.61, 2.11) 1.10 (0.58, 2.05)
Quintile 4 (1.90–2.70) 115/738 1.28 (0.72, 2.27) 1.26 (0.70, 2.27) 1.21 (0.67, 2.22)
Quintile 5 (2.80–54.00) 164/740 1.48 (0.84, 2.62) 1.43 (0.80, 2.57) 1.36 (0.75, 2.48)
p-Trend 0.041 0.084 0.120
aHearing loss was defined as pure tone average at speech frequencies (0.5, 1, 2, and 4 kHz) > 25 dB. bModel A was 
adjusted for age, age2, sex, race/ethnicity, education, BMI, ototoxic medication, pack-years of cigarette smoke, hyper-
tension, and diabetes. Cadmium models were further adjusted for lead; lead models were further adjusted for cadmium. 
cModel B adjusted for all variables included in model A and further adjusted for occupational noise. dModel C adjusted 
for all variables in model B and further adjusted for recreational noise, and firearm noise.
Table 4. Percent change (95% CI) in hearing thresholds (dB) by joint effect between blood cadmium and 
lead levels (n = 3,698).
Variables Low cadmium High cadmium
Cadmium within 
strata of lead
Low lead Reference 7.33 (0.38, 14.77)  
p = 0.044
7.33 (0.38, 14.77) 
p = 0.044
High lead 10.09 (0.35, 20.78) 
p = 0.048
19.01 (9.68, 29.13) 
p < 0.001
8.1 (–0.87, 17.87) 
p = 0.085
Lead within strata 
of cadmium
10.09 (0.35, 20.78) 
p = 0.048
10.88 (3.40, 18.90) 
p = 0.006
Measure of interaction on additive scale: RERI = 1.6%; 95% CI: –9.4, 12.6%; p = 0.778. Measure of interaction on multi-
plicative scale: percent change of interaction term = 0.7%; 95% CI: –8.9, 11.39%; p = 0.891. Models were adjusted for 
age, age2, sex, race/ethnicity, education, BMI, ototoxic medication, cumulative cigarette pack-years, current diagnosis 
of hypertension, current diagnosis of diabetes, and occupational, recreational, and firearm noise. Cadmium models 
were further adjusted for lead, and lead models were further adjusted for cadmium.
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OR for hearing loss of 1.1 (95% CI: 1.0, 1.3) 
with a doubling in blood lead, which extends 
the body of evidence concerning lead and 
hearing loss to men and women in the United 
States as a whole.
To our knowledge, this is the first 
epidemio logic study to evaluate associations 
between hearing loss and cadmium exposure 
in adults. A few experimental studies have 
suggested possible mechanisms for cadmium 
ototoxicity. Studies using rats exposed to cad-
mium-contaminated drinking water suggested 
that cadmium can induce the generation of 
reactive oxygen species, loss of mitochon-
drial membrane depolarization, release of 
cytochrome c, activation of caspases, apop-
tosis, and the increase of extracellular signal-
regulated kinase activation in auditory cells 
leading to an elevation in auditory thresh-
olds (Kim et al. 2008; Ozcaglar et al. 2001). 
A recent study of U.S. adolescents from 
NHANES 2005–2008 reported a significant 
association between urinary cadmium and 
low-frequencies hearing loss (defined as the 
average of thresholds at 0.5, 1, and 2 kHz 
> 15dB) (Shargorodsky et al. 2011).
The present study suggests that low-level 
exposures to cadmium and lead currently 
observed in the U.S. general population may 
influence hearing health and supports efforts 
to reduce environmental cadmium and lead 
exposures. Compared with participants with 
exposures in the first quintiles, those in the 
fifth quintiles of blood cadmium (0.80–8.50 
µg/L) and blood lead (2.80–54.0 µg/dL) are at 
risk for poorer hearing ability. Occupational 
Safety and Health Administration safety stan-
dards are currently 44.5 nmol/L (5 µg/L) 
for cadmium and 1.93 µmol/L (38.6 µg/dL) 
for lead in whole blood (Agency for Toxic 
Substances and Disease Registry 2010a, 
2010b). Very few participants in our study 
population exceeded these limits (0.11% 
and 0.05% of participants for cadmium and 
lead standards, respectively); therefore, our 
findings may at least partly reflect effects on 
hearing below these levels. Evidence of pos-
sible effects of blood lead and cadmium at 
levels below current standards has also been 
reported for outcomes such as hypertension, 
chronic kidney disease, and peripheral arterial 
disease (Guallar et al. 2006; Navas-Acien et al. 
2009; Tellez-Plaza et al. 2008). In the general 
population, the primary sources of cadmium 
exposure are cigarette smoke, dietary intake 
(shellfish, offal, vegetables), and ambient air, 
particularly in urban, industrial, and contami-
nated agricultural areas (Järup et al. 1998). 
Although primary historical sources of lead 
exposure (gasoline, solder, and paint) have 
been phased out and environmental lead 
exposure has decreased considerably in the 
United States (Hu et al. 2007; Muntner et al. 
2005), environmental exposure to low levels 
of both metals is still widespread (Department 
of Health and Human Services 2005; 
Muntner et al. 2005), and their accumulation 
in the body could influence the development 
of chronic diseases (Hu et al. 2007; Nordberg 
et al. 2007).
The present study found a joint effect of 
combined exposure to high cadmium and 
high lead on increased hearing thresholds, 
although formal hypotheses testing for addi-
tive and multiplicative interaction was not 
observed to be significant. The estimated joint 
effect of lead and cadmium was consistent 
with additive combined effects of the expo-
sures on hearing resulting in an estimated 
19% increase in thresholds in those with high 
lead and cadmium levels compared with those 
with low levels of exposure to both metals. 
Cadmium and lead share several similarities in 
molecular mechanisms implicated in toxicity. 
Both metals are divalent cations that interrupt 
sulfhydryl-containing enzymes, and induce 
reactive oxygen species increase via oxidation–
reduction–inactive metal (Ercal et al. 2001; 
Vaziri and Khan 2007). They are also asso-
ciated with changes in intracellular calcium 
homeostasis (Sabolić 2006), and finally co- 
exposure to both metals may act synergisti-
cally in auditory hair cell death and hearing 
loss. Few studies have estimated a joint effect 
of cadmium and lead exposures on other 
health outcomes. Navas-Acien et al. (2009) 
investigated the association of lead and cad-
mium with renal function in > 15,000 adults 
in the NHANES 1999–2006 and observed 
a significant interaction between cadmium 
and lead for albuminuria (p = 0.003), based 
on the model that included the product of 
the two log-transformed metals. Another 
study that examined the associations of uri-
nary cadmium and blood lead with reproduc-
tive hormones in > 700 young women in the 
NHANES III also found a stronger estimated 
effect by both high cadmium and lead in 
reducing inhibin B level, compared with high 
lead alone (Gollenberg et al. 2010).
Hypertension and diabetes may be 
potential causal intermediates rather than 
confounders because they are risk factors for 
hearing loss (Bainbridge et al. 2008; Chang 
et al. 2011) and are health outcomes that may 
be caused by cadmium and lead exposures 
(Hu et al. 1996; Schwartz et al. 2003; Tellez-
Plaza et al. 2008). Therefore, we compared 
estimates from models that included all 
covariates (model A in Tables 2 and 3) 
Figure 1. Multivariate-adjusted percent change (95% CI) in hearing thresholds (dB) per doubling of 
cadmium and lead by participant characterisctic.
–20 –10 10 20 30 0–20 –10 10 20 300
Percent change in thresholds Percent change in thresholds
Cadmium Lead
 Whole 3,698
 Age 20–39 years 1,650
 Age 40–59 years 1,385
 Age ≥ 60 years 663
 Men 1,729
 Women 1,969
 BMI < 30 kg/m2 2,484
 BMI ≥ 30 kg/m2 1,214
 Non-Hispanic white 1,827
 Non-Hispanic black 750
 Mexican American 805
 Other 316
 < High school 974
 High school 849
 > High school 1,875
 Nonototoxic medication user 3,132
 Ototoxic medication user 566
 Never smoker 410
 Light smoker < 20 pack-years 1,183





 Low-occupational noise 1,815
 High-occupational noise 1,883
 No firearm noise 3,468
 Firearm noise 230
 No recreational noise 2,844
 Recreational noise 854
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except hypertension and diabetes, and found 
the associations were not changed when 
hypertension and diabetes were excluded (data 
not shown).
Another possible explanation for the 
observed associations of cadmium and lead 
with shifts in hearing thresholds is that both 
metal exposures lower bone mineral density 
(BMD) (Alfvén et al. 2002; Chen et al. 2011) 
and affect chronic kidney disease (CKD) 
(Kim et al. 1996; Navas-Acien et al. 2009), 
which could mediate effects of these metals on 
hearing loss. This suggestion is supported by 
several bone disease studies that have observed 
a high correlation between BMD changes in 
cochlear capsule and sensorineural hearing 
loss (Güneri et al. 1996; Monsell et al. 1995) 
and kidney studies that indicated an asso-
ciation between reduced glomerular filtration 
rate (an indicator of CKD) and hearing loss 
(Vilayur et al. 2010).
The important strengths of this study 
include the use of data from a representa-
tive sample of the U.S. general population, 
which supports generalization of the observed 
findings; adjustment for potentially impor-
tant confounding factors, including occupa-
tional noise classified using a newly developed 
assessment tool based on O*NET (Choi et al. 
2012), and nonoccupational noise exposures; 
and the use of NHANES, which uses strict 
QC procedures.
Several limitations in this study should be 
considered. The present study was conducted 
in a cross-sectional design that may raise an 
issue of validity of causal inferences between 
lead and cadmium exposures and hearing loss. 
Blood lead mainly reflects recent exposure, 
and therefore may not be a good biomarker 
to predict the long-term effect of low-level 
lead exposure, such as chronic diseases includ-
ing hearing loss (Hu et al. 2007). Instead, 
bone lead has been suggested as a better bio-
marker of cumulative lead exposure (Hu et al. 
2007), and a recent study conducted in east-
ern Massachusetts showed a significant asso-
ciation between bone lead and age-related 
hearing loss (Park et al. 2010). Given that the 
measurement error of exposure is likely to be 
nondifferential, we would expect that the true 
association might be larger. Blood cadmium 
generally reflects current exposure, whereas 
urinary cadmium is considered cumulative 
exposure. However, both blood and urinary 
cadmium are considered the accumulated 
body burden in general populations with 
“low” level environmental exposure (Järup 
et al. 1998). We were not able to examine the 
association with urinary cadmium because 
urinary cadmium measures and audiometric 
tests were conducted in different subsets of 
NHANES 1999–2004 participants and the 
number that were included in both subsets is 
too small for a reliable statistical analysis.
In conclusion, the present study supports 
the hypothesis that environmental cadmium 
and lead exposures at levels currently observed 
in the United States may increase the risk of 
hearing loss, the third leading chronic con-
dition experienced by adults ≥ 65 years of 
age (Yueh et al. 2003). Our findings support 
efforts to reduce environmental cadmium and 
lead exposures to effectively prevent or delay 
hearing loss in the general population.
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